The extramural community is informed this Guide Notice about NIH's adoption of Common Forms for Biographical Sketch and Current and Pending (Other) Support to be used with all applications and Research Performance Progress Report(s) (RPPRs) by May 25, 2025.

This Notice is to let potential applicants know about an upcoming webinar on planning submissions to promote diversity initiatives in the NIH's Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Program, K99/R00 (PAR-24-225, PAR-24-226, and PAR-24-227) and UE5 (PAR-24-224) NOFOs.

Topic: Preparing an Application to the NIH Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Program

During this webinar, you will learn about the MOSAIC program and tips for writing a K99/R00 or UE5 application.

Date: Thursday, August 29, 2024

Time: 1:00 - 3:00 PM EDT

Please click the link here to join the webinar:

Meeting ID: 161 286 2780

Passcode: NIGMS

On Tuesday, September 17, 2024, NIH experts are inviting you to attend a webinar to better understand the required reports and related policies. Acquire insights into topics such as:

   Final Research Performance Progress Report (RPPR)

   Final Invention Statement

   Final Federal Financial Report (FFR)

   And more!

Webinar: NIH Grant Closeout Process: Administrative and Financial Essentials

   Date: Tuesday, September 17, 2024 

   Time: 1:00 – 2:00 p.m. ET

   Free virtual event. Registration Required

Starting with applications received on or after September 25, 2024, NIAID will limit the total number of predoctoral and/or postdoctoral training slots to a maximum of 8 trainee slots/training grant in any given year for the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) or any reissuance of this funding opportunity as an operational accommodation due to budgetary constraints. This is for both competitive and non-competitive T32 grants.

Current NIAID T32 grantees with 10 or more than 10 trainee slots/year will need to reduce their number of slots by not replacing vacant slots until the 8-slot limit is reached and maintained. For competitive renewal (T2) applications, the maximum increase in trainee slots from the previous non-competiting (T5) year will be 2, with a maximum 8-slot limit.

Prior approval is now required for SBIR and STTR recipients to add a new domestic subaward to a project, post award, where the arrangement was not originally included in the peer-reviewed and approved application. NIH still requires approval before adding a foreign subaward to the project. The new prior approval requirement is intended to assist recipients in monitoring their relationships with countries of concern and prevent security risk findings for subawards post award.

Starting October 1, 2024, foreign recipients (either serving as a direct or subrecipient of NIH grants and cooperative agreements) who expend $750,000 (cumulative amount) or more in Federal awards during their fiscal year will be required to conduct either a single audit, performed in accordance with the requirements outlined in 2 CFR 200 Subpart F, or program-specific audit.

For due dates on or after January 25, 2025, FORMS-I application packages should be used by applicants, while FORMS-H application packages should be used for due dates on or before January 24, 2025. If applications are submitted with an incorrect forms package for their intended due date, they will be withdrawn and removed from funding consideration.

On January 25, 2025, the NIH is going to update two practices under the NIH Genomic Data Sharing (GDS) Policy to continue to promote responsible data management and access. The goal of these changes is to make sure that GDS Policy implementation keeps up with the changing practices of collecting, sharing, and using controlled-access human genomic data, which includes - (1) modernizing security standards provided in the “NIH Security Best Practices for Controlled-Access Data Subject to the NIH Genomic Data Sharing (GDS) Policyand (2) establishing minimum expectations for developers' access to controlled-access data.

 1.The Kidney Cancer Research Program (KCRP) released the following funding opportunities:

·       Academy of Kidney Cancer Investigators Leadership Award (New for FY24)

·       Concept Award

·       Postdoctoral and Clinical Fellowship Award

2.The Neurofibromatosis Research Program (NFRP) released the following funding opportunities:

·       Clinical Trial Award

·       Exploration Hypothesis Development Award

·       Early Investigator Research Award

·       Investigator Initiated Research Award

·       Neurofibromatosis Research Award Leadership Award (New for FY24)

·       New Investigator Award

·       Synergistic Idea Award

3.The Breast Cancer Research Program (BCRP) released program announcements for the following funding opportunities:

·       Breakthrough Award Levels 1 and 2

·       Clinical Research Extension Award

·       Era of Hope Scholar Award

·       Transformative Breast Cancer Consortium Development Award

The College of Medicine would like to submit one candidate’s application for consideration for the 2025 Searle Scholars Program from the Kinship Foundation. The Searle Scholars Program Scientific Advisory Board is primarily interested in the potential of applicants to make innovative and high-impact contributions to research over an extended period of time. 

Grants are set at $300,000 for a three-year period with $100,000 payable in the first year and equal sums payable in the second and third years and are subject to the receipt of acceptable progress reports. Generally, fifteen new awards are granted annually. Awards will be activated on July 1, 2025. 

Eligibility of the applicant: 

• Applicants should have begun their appointment as an independent investigator at the Assistant Professor level on or after May 1, 2023. The appointment must be their first tenure-track position. 
• Applicants are expected to be pursuing independent research careers in biochemistry, cell biology, genetics, immunology, neuroscience, pharmacology, and related areas in chemistry, medicine, and the biological sciences. 
• The Searle Scholars Program does not ordinarily support purely clinical research but has supported research programs that include both clinical and basic components. Potential applicants who are unsure if their research is appropriate for the Program are encouraged to examine the research interests of present and former Searle Scholars on this website. The 2023 Searle Scholars are listed here. 

In order to implement the application process for this competition, eligible faculty members are invited to submit preliminary applications, upon the recommendation of the appropriate department chair(s), for review by the Awards Committee. From among these applications, the Committee will make recommendations and will select one candidate, who will be invited to submit the full proposal to the Kinship Foundation by 5:00 pm, September 30, 2024. 

The deadline for submission of preliminary applications for internal review by the Awards Committee is Friday 5 pm, August 16^th, 2024. 

For internal review of your application by the Awards Committee, please send a single (ONE) PDF file containing the following as an email attachment to indranil.basu@einsteinmed.edu: 

1. Candidate Profile Form; download from this link. 
2. A statement outlining the applicant’s career potential and the Department’s plans for his/her future to be obtained from the Department Chairperson, limited to no more than TWO single-spaced pages. 
3. A written proposal containing a title and a description of the proposed research project to be carried out during the grant period, limited to no more than three single-spaced pages, plus one additional page (single spaced) for references with titles included. The font must be 11 point or larger, and the margins should be at least 0.5 inches. Figure legends can use smaller fonts. 
4. A complete curriculum vitae and bibliography. Include invited presentations but not abstracts. Please click here to find the recommended format for curriculum vitae. 
5. Information about present and pending grant support with amounts requested or approved, annual amounts, and duration of award. 

To know in advance about the award and reporting requirements by the Kinship Foundation, please visit the Searle Scholars Program Award Information Page. The Searle Scholars Program accepts nominated applications only through their online application system. Once our Awards Committee selects the nominee, we will assist the nominated candidate to submit the final application to the Kinship Foundation. 

If you have any questions concerning this award or the application procedure, please contact indranil.basu@einsteinmed.edu. 

The College of Medicine has been invited to submit one candidate’s application for consideration for the 2025 Rita Allen Foundation Scholars Program. The Program funds basic biomedical research in the fields of cancer, immunology, and neuroscience and supports early-career biomedical scholars and their research to advance transformative ideas and leverage them for promoting breakthrough solutions. They seek research projects with above-average risk and promise. 

Eligibility of the applicant:  

Candidates should have completed their training and shown persuasive evidence of distinguished achievement or extraordinary research promise in the fields of cancer, immunology, or neuroscience. They should be independent investigators appointed to tenure-track positions and in the early stages of their careers and research. 

It is preferable that candidates be in the first three years of their tenure track. 

Candidates must have received committed startup funds from the institution. 

Candidates must have lab space from the institution. 

The Rita Allen Foundation Scholars Program is intensely competitive. The awardees will receive financial support from the Foundation of up to $110,000 annually, for a period of up to five years. 

In order to implement the application process for this competition, eligible faculty members are invited to submit preliminary applications, upon the recommendation of the appropriate department chair(s), for review by Einstein's Awards Committee. From among these applications, the Committee will make recommendations and will select one candidate, who will be invited to submit a full proposal to the Foundation. 

The deadline for submission of preliminary applications, for internal review by the Awards Committee, is on or before Friday, August 16, 2024 by 5 PM. 

For internal review of your application by the Awards Committee, please send a single (ONE) PDF containing the following as an email attachment to: 

indranil.basu@einsteinmed.edu: 

1. Candidate Profile Form; download from Candidate Profile Form 

2. A statement outlining the applicant’s career potential and the Department’s plans for his/her future to be obtained from the Department Chairperson, limited to no more than two single-spaced pages. 

3. A written proposal containing a title and a description of the proposed research project to be carried out during the grant period, limited to no more than three single-spaced pages, plus one additional page (single-spaced) for references with titles included. The font must be Arial, 11-point or larger, and the margins should be at least 0.5 inches. Figure legends can use smaller fonts. 

4. A complete curriculum vitae and bibliography. Include invited presentations but not abstracts. Please click here to find the recommended format for curriculum vitae. Do not submit an NIH Biosketch. 

5. Information about present and pending grant support with amounts requested or approved, annual amounts, and duration of award. 

If you have any questions concerning this award or the application procedure, please contact indranil.basu@einsteinmed.edu.

The Development Office would like to share guidelines for the Fall 2024 Mathers Foundation grant cycle. Our institution may nominate up to 3 applicants in basic science. 

Submit your project proposals by 5:00 p.m. on Friday, August 23, 2024.

Please note the Development team will handle all LOI submissions. If you have additional questions, please do not hesitate to reach out to institutionalgiving@montefiore.org.

The G. Harold and Leila Y. Mathers Foundation Research Grants – Limited Submission

• Due: October 4, 2024 (LOI)
• Amount: $600,000-$700,000 over 3 years, including 10% indirect rate
• “The mission of The G. Harold and Leila Y. Mathers Foundation is to advance knowledge in the life sciences by sponsoring scientific research that will benefit mankind. Basic scientific research, with potential translational application, is central to this goal, and fundamental to our operating principles.” While the foundation is interested in translational applications, the focus of the proposal should be in basic science. The research should demonstrate potential for significant breakthroughs in the field. Proposals should be high risk/high reward and show a new direction from the PI’s prior efforts. Areas of interest include: Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience.

• The foundation will not fund COVID-19 research, medical imaging, electrical engineering technology, or plant biology. The foundation also will not fund clinical trials, drug discovery or pre-clinical drug development. Previously declined LOIs/proposals may not be resubmitted. Renewal requests are discouraged. Renewal requests must focus on new directions, “not merely an extension of previously funded research.” Applications with pending federal approval are not given priority.

• Eligibility: To be competitive, the PI must have an independent laboratory, and have a history of “impactful discoveries” and published research studies to share in the LOI phase. While not required, it is recommended that the PI be tenured or in a tenure-track position.

• Selection Process: The Einstein Awards Committee will select up to 3 applicants. PIs should not register in the grant portal until the committee’s decisions are communicated (in mid-September). All LOI submissions must go through the Development Office. If the foundation receives more than 3 submissions from our institution, all Einstein proposals will be disqualified.

• PIs should provide a one page project summary using the template attached, and their CV/biosketch, to institutionalgiving@montefiore.org by 5:00 p.m. on August 23. If you have any questions about the foundation or the application process, please contact institutionalgiving@montefiore.org. 

• Link: Grant Program Overview | Mathers Foundation

Empire State Development’s Division of Science, Technology, and Innovation (“NYSTAR”), Innovation Matching Grants Program (the “IMG Program”) aims to grow small businesses and support the development of new technologies in New York State by providing matching funds for federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants.

The New York State Innovation Matching Grants Program will match: 

The award for Phase I applicants, not to exceed $100,000. 

The award for Phase II applicants, not to exceed $200,000. 

and provide technical assistance resources for Phase II and Phase III awards. 

In no event, shall the funding provided from the IMG Program exceed 50% of the federal award. A funding commitment made through the IMG Program demonstrates New York State support to strengthen certain proposals, increase the likelihood that New York State businesses will be awarded competitive federal SBIR/STTR funding, and supports the growth of promising small businesses in New York. Click here for more details.

LLS has released a Request for Proposals (RFP) for its Equity in Access Research Program, which is aimed at funding research in health services. LLS is reissuing their RFP that aims to increase the number of patients who participate in therapeutic cancer clinical trials by promoting access for underrepresented groups. Awards will be a maximum of $2.5 million each over 5 years.

In particular, LLS is in search of proposals that will implement and evaluate interventions that are designed to:

• Mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups
• Quantitatively measure the impact of these interventions on patient accrual

Proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation are of particular interest to us. It is not necessary for applicants to have previously conducted research in blood cancer. 

Letters of Intent must be submitted by September 12, 2024 at 3pm ET.

Visit LLS.org/EquityinAccess for the RFP and additional information. If you have any inquiries, please contact researchprograms@lls.org.

The Robert L. Fine Cancer Research Foundation has announced an upcoming funding opportunity in basic and translational pancreatic cancer research. The grant is for $250,000 in direct costs over a two year period. The award is targeted at new and recently established physicians and/or scientists who are dedicated to innovative translational research that would be deemed too risky for funding from conventional government sources. The deadline for the application is August 31^st, 2024 and further details for grant submission can be found at www.rlfcrf.org. 

If there are any questions, please contact the foundation at grants@rlfcrf.org.

Amount: $150,000 for 1 year

Deadline: August 31, 2024

The foundation funds innovative approaches to identifying new treatments or cures for cancer. Projects are for a one-year period to allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified. Grant amount requested must be reasonable and clearly supported by the scope of the project outlined in the application. The Foundation particularly welcomes innovative, small-scale, short-term projects which may be difficult to fund elsewhere until some interesting results are obtained.

Priority is given to researchers who are new to the field of cancer research, or to established research investigators examining new approaches to cancer.

Link: How to Apply

Contact: Audrey McInerney (amcinerney@montefiore.org) for additional information and/or assistance.

This program's objective is to encourage specialized training in the early stages of career development, provide exposure to CF research and patient care, and to prepare well-qualified candidates for careers related to CF. The Foundation is in search of programs that incorporate significant time and exposure in outpatient CF clinics into the first and second-year fellow curriculum.

Full applications are due by September 4, 2024.

Applications must be submitted online at awards.cff.org by 5 p.m. ET.

• Due: September 6, 2024

• Amount: $200,000 over 2 years

This award is intended for experienced researchers “seeking to make consequential translational discoveries that will drastically alter clinical care for pregnant women and babies, whether through evidence-based prevention, diagnosis or intervention. “Eligible areas of research are: (1) Late, spontaneous pre-term birth; (2) Racial inequities as they relate to morbidity and mortality outcomes for mothers and babies; (3) Cardiovascular health conditions developed during pregnancy or exacerbated during pregnancy; (4) Maternal stress, its impact on pregnancy outcomes, and how to mitigate the effects. Applicant should have significant history of published work. Open to health professionals, health researchers, epidemiologists and social scientists with doctoral academic degrees, and either a faculty appointment or equivalent at academic universities, hospitals and research institutions.

• Link: Discovery Research Grants I March of Dimes

• Contact: Audrey McInerney (amcinerney@montefiore.org) for additional information and/or assistance.

Due: September 12, 2024

Amount: $900,000 over 3-4 years

The aim is to understand whether and how developmental phenotypes caused by autism risk gene mutation lead to altered circuit formation and function. The foundation strongly encourages proposals involving close collaboration between investigators of diverse expertise, such as developmental neurobiologists and circuit neuroscientists to collaboratively conduct thorough characterizations of how early developmental events result in alterations to ASD-relevant neural circuitry in carefully chosen models. All applicants and key collaborators must hold a Ph.D., M.D. or equivalent degree and have a faculty position or the equivalent. The foundation encourages inclusion of researchers who span career stages.

Link: Neurodevelopment to Neural Circuit Outcomes RFP

Contact: Audrey McInerney (amcinerney@montefiore.org) for additional information and/or assistance.

Award Categories:

Scholar. These 5-year, $120,000/year awards support emerging leaders in the blood cancer research field. You must be a highly qualified, early/mid-career laboratory-based investigator who has an impactful and innovative research program focused on hematologic malignancies and/or relevant premalignant conditions. You must hold an independent, tenure-track, faculty-level position and should have substantial research support from a national agency.

Scholar in Clinical Research. These 5-year, $125,000/year awards support highly qualified clinical investigators who hold an independent faculty-level appointment and are conducting independent applied research that will advance the prevention, diagnosis, and/or treatment of hematologic malignancies and/or relevant premalignant conditions. The research must involve patients and be related to your overall clinical activities. You must have substantial support for your research from another source.

Special Fellow. These 2 or 3 year, $75,000/year awards support highly qualified, mentored postdoctoral fellows and instructors who have 3-5 years of postdoctoral research training (as of the award start date) and are continuing a research program of direct relevance to hematological malignancies and/or relevant premalignant conditions. In addition, your Sponsor must have the appropriate experience to mentor you as you engage in blood cancer research. This award provides you with the opportunity to continue building a research program that will make you competitive for an independent position by the end of the award funding period.

Fellow. These 3-year, $70,000/year awards support top performing, mentored postdoctoral fellows and instructors who are training for a career in hematological malignancy research and/or treatment and who have up to 3 years of postdoctoral research training (as of the award start date). Your Sponsor must have the appropriate experience to mentor you as you engage in blood cancer research.

Application Process:

The application process has three phases. The first phase is submission and consideration of eligibility. All eligible applicants will be invited to proceed to the Letter of Intent and Full Application phases. All submissions must be made through the LLS Research Portal.

Please visit the website for how to apply. Detailed instructions for each award category are found in the CDP Guidelines and Instructions. For questions, please contact researchprograms@lls.org.

AHA Predoctoral Fellowship

Proposal deadline: Wednesday, September 4, 2024

Enhances the training of promising students in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists, or related careers aimed at improving global health and wellbeing.

AHA Postdoctoral Fellowship

Proposal deadline: Thursday, September 5, 2024

Enhances the training of postdoctoral applicants who are not yet independent. The applicant must be embedded in an appropriate investigative group with the mentorship, support, and relevant scientific guidance of a research mentor.

AHA Institutional Research Enhancement Award (AIREA)

Proposal deadline: Thursday, September 12, 2024

Stimulates research at educational institutions that provide baccalaureate or advanced degrees related to scientific research training. Eligible institutions may not have been major recipients of NIH support. Awards provide funding for small-scale research projects related to cardiovascular and cerebrovascular topics, enhancing the research environment at eligible institutions, and exposing students to research opportunities.

Career Development Award

Proposal deadline: Wednesday, December 5, 2024

Supports highly promising healthcare and academic professionals in the early years of first professional appointment to assure the applicant’s future success as a research scientist in the field of cardiovascular and/or cerebrovascular disease research.

Research Supplement to Promote Diversity in Science

Proposal deadline: Thursday, February 6, 2025

To enable current AHA awardees to identify and serve as mentors for predoctoral and postdoctoral fellows from underrepresented groups in science and medicine.